Search

Current filters: HIV drugs, HIV, Treatment, Raltegravir (Isentress, Isentress HD)

Isentress HD (raltegravir once daily)

2018, CATIE
Fact sheet - Webpage

Isentress (raltegravir twice daily)

2018, CATIE
Fact sheet - Webpage

CDC recommends use of raltegravir (Isentress) for PEP

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Isentress HD in clinical trials

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Isentress HD—a new once-daily formulation of raltegravir approved in Canada

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Canadian researchers review the use of raltegravir in pregnancy

2016, CATIE
Research summary - Webpage

U.S. study reviews use and impact of integrase inhibitors in pregnancy

2016, CATIE
Research summary - Webpage

Comparing the tolerability and effectiveness of initial therapy

From TreatmentUpdate 202
2014, CATIE
Research summary - Webpage

Dual therapy with raltegravir and darunavir

From TreatmentUpdate 202
2014, CATIE
Research summary - Webpage

Raltegravir in women and reduced soluble CD14

From TreatmentUpdate 201
2014, CATIE
Research summary - Webpage